Royal Biologics Partners with Vilex for Lower Extremities

Royal Biologics ALC Therapies

Royal Biologics entered into a distribution agreement whereby Vilex will market and distribute Royal Biologics' portfolio of Autologous and Live Cellular therapies for lower extremity orthopedic procedures.

Royal's product portfolio focuses on fully utilizing the potential of the patient's own cells to maximize efficacy in bone graft and wound...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us